Journal article · 2024 · Open access
Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy
Journal of Student Research, 13(1) · Published 29 February 2024 · DOI 10.47611/jsrhs.v13i1.6455
In brief
“Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy” is a 2024 journal article by Alexander Xu and Emily Reynolds, published in Journal of Student Research. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at Journal of Student Research.
- Citations
- 0
- References
- 42
- Authors
- 2
Abstract
PROteolysis TArgeting Chimera (PROTAC) technology is an effective tool to induce targeted degradation of pathogenic protein and is a novel cancer therapy. It uses the endogenous ubiquitin‐protease system (UPS), attracting ubiquitin and covering the target protein in it, thus resulting in its complete degradation of the protein interest (POI). The potential advantages of PROTAC technology compensate for the shortcomings of traditional cancer therapy and allow them to target “undruggable” proteins, which promote its rapid development in recent years. The review focuses on the mechanisms of PROTACs, discusses application of PROTACs targeting different oncogenic proteins and analyzes the strategies for designing efficient PROTACs. Collectively, the review provides references for future application of PROTACs in cancer treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xu, A., & Reynolds, E. (2024). Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy. Journal of Student Research, 13(1). https://doi.org/10.47611/jsrhs.v13i1.6455
MLA 9
Xu, Alexander, and Emily Reynolds. “Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy.” Journal of Student Research, vol. 13, no. 1, 2024. https://doi.org/10.47611/jsrhs.v13i1.6455.
Chicago
Xu, Alexander and Emily Reynolds. 2024. “Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy.” Journal of Student Research 13 (1). https://doi.org/10.47611/jsrhs.v13i1.6455.
Harvard
Xu, A. and Reynolds, E. (2024) ‘Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy’, Journal of Student Research, 13(1). doi:10.47611/jsrhs.v13i1.6455.
IEEE
A. Xu and E. Reynolds, “Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy,” Journal of Student Research, vol. 13, no. 1, 2024, doi: 10.47611/jsrhs.v13i1.6455.
BibTeX
@article{xu2024targeted,
title = {{Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy}},
author = {Xu, Alexander and Reynolds, Emily},
journal = {Journal of Student Research},
year = {2024},
volume = {13},
number = {1},
doi = {10.47611/jsrhs.v13i1.6455},
url = {https://doi.org/10.47611/jsrhs.v13i1.6455}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- targeted protein degradation
- cancer therapy
- ubiquitin-proteasome system
- undruggable proteins
- oncoprotein
- PROTAC design
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Xu, A., & Reynolds, E. (2024). Targeted Protein Degradation Technology: A Novel Strategy for Cancer Therapy. Journal of Student Research, 13(1). https://doi.org/10.47611/jsrhs.v13i1.6455
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Student Research: sign in and open the full text from this page.
Who wrote this paper?
Alexander Xu, Emily Reynolds.
What is the DOI of this paper?
10.47611/jsrhs.v13i1.6455, permanently at https://doi.org/10.47611/jsrhs.v13i1.6455. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.